Drugs · acquisition-cost intelligence
Fluticasone Propionate HFA
fluticasone propionate· ingredient fluticasoneCorticosteroids· FLUTICASONE PROPIONATE 110 ug/1; FLUTICASONE PROPIONATE 220 ug/1; FLUTICASONE PROPIONATE 44 ug/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$12.55
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 7 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other fluticasone products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| fluticasone propionate | $0.35931 | −$12.19 |
| Fluticasone Propionate | $0.56876 | −$11.98 |
| 24 Hour Allergy Nasal | $0.68437 | −$11.87 |
| FLOVENT DISKUS | $2.12 | −$10.44 |
| fluticasone propionate | $3.14 | −$9.42 |
| Arnuity Ellipta | $6.65 | −$5.90 |
Medicare Part D coverage · CY2026
On 124 plan formularies · typical tier 4
Prior auth 0% · Step therapy 20% · Quantity limit 96% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.